1. Volume 52, Issue 4, Pages 1058-1066 (October 2007)
Outcome of Prostate Cancer Patients with Initial PSA≥20ng/ml Undergoing Radical Prostatectomy 
Ulrike Zwergel, Henrik Suttmann, Thomas Schroeder, Stefan Siemer, Bernd Wullich, Joern Kamradt, Jan Lehmann, Michael Stoeckle 
European Urology 
Volume 52, Issue 4, Pages (October 2007)
DOI: /j.eururo
Copyright © 2007 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan-Meier overall and cause-specific survival curves of 275 patients with initial prostate-specific antigen (PSA) ≥20ng/ml who were treated with radical prostatectomy. (a) Overall survival. (b) Overall survival survival comparing 129 patients with immediate (1) and 146 with surveillance (i.e. deferred (2) postoperative hormonal treatment (HT) in case of PSA rising). The Kaplan Meier analysis showed no significant difference in overall survival between both subgroups (p=0.193). (c) Cancer specific survival. (d) Cancer specific survival comparing 129 patients with immediate (1) and 146 with surveillance (i.e deferred (2) postoperative HT in case of PSA rising). The Kaplan Meier analysis showed no significant difference in cancer specific survival between both subgroups (p=0.128).
European Urology  , DOI: ( /j.eururo )
Copyright © 2007 European Association of Urology Terms and Conditions